Efficacy of rituximab in patients with Graves’ orbitopathy: a retrospective multicenter nationwide study

被引:0
|
作者
Jean-Baptiste Deltour
Marie d’Assigny Flamen
Miriam Ladsous
Lama Giovansili
Bertrand Cariou
Philippe Caron
Delphine Drui
Pierre Lebranchu
机构
[1] CHU Nantes,Department of Ophthalmology, Hotel Dieu
[2] CHU Nantes,Department of Endocrinology Diabetes and Nutrition, L’institut du thorax
[3] Department of Endocrinology CHRU Lille,Department of Internal Medicine, Section of Endocrinology
[4] Fondation Ophtalmologique A de Rothschild,Department of Endocrinology, Metabolic Diseases and Nutrition, Pôle Cardio
[5] CHU Toulouse,Vasculaire et Métabolique
来源
Graefe's Archive for Clinical and Experimental Ophthalmology | 2020年 / 258卷
关键词
Rituximab; Anti-CD20 antibody; Graves’ orbitopathy; Basedow’s disease; Clinical activity score (CAS);
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2013 / 2021
页数:8
相关论文
共 50 条
  • [11] Tocilizumab versus Rituximab in Patients with Moderate to Severe Steroid-resistant Graves' Orbitopathy
    Bennedjai, Amin
    Bouheraoua, Nacim
    Gatfosse, Marc
    Dupasquier-Fediaevsky, Laurence
    Errera, Marie-Helene
    Tazartes, Michel
    Borderie, Vincent
    Hennocq, Quentin
    Della, Azeddine
    Riviere, Sebastien
    Heron, Emmanuel
    Fain, Olivier
    Mekinian, Arsene
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2022, 30 (02) : 500 - 505
  • [12] Orbital decompression in Graves' orbitopathy: efficacy and safety
    Goh, MSY
    McNab, AA
    INTERNAL MEDICINE JOURNAL, 2005, 35 (10) : 586 - 591
  • [13] THE EFFICACY OF RADIATION THERAPY IN THE TREATMENT OF GRAVES' ORBITOPATHY
    Matthiesen, Chance
    Thompson, J. Spencer
    Thompson, David
    Farris, Bradley
    Wilkes, Byron
    Ahmad, Salahuddin
    Herman, Terence
    Bogardus, Carl, Jr.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (01): : 117 - 123
  • [14] Statin Use and the Risk of Graves' Orbitopathy: A Nationwide Population-Based Cohort Study
    Chou, Yu-Tsung
    Lai, Chun-Chieh
    Li, Chung-Yi
    Shen, Wei-Chen
    Huang, Yu-Tung
    Wu, Yi-Lin
    Lin, Yi-Hsuan
    Yang, Deng-Chi
    Yang, Yi-Ching
    THYROID, 2025, 35 (02) : 199 - 207
  • [15] Facial expression of patients with Graves' orbitopathy
    Lei, C.
    Qu, M.
    Sun, H.
    Huang, J.
    Huang, J.
    Song, X.
    Zhai, G.
    Zhou, H.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2023, 46 (10) : 2055 - 2066
  • [16] Facial expression of patients with Graves’ orbitopathy
    C. Lei
    M. Qu
    H. Sun
    J. Huang
    J. Huang
    X. Song
    G. Zhai
    H. Zhou
    Journal of Endocrinological Investigation, 2023, 46 : 2055 - 2066
  • [17] Endoscopic and transcaruncular medial wall decompression in unilateral graves’ orbitopathy: a multicenter randomized study
    El-Samkary M.A.
    El-Sersy H.A.
    The Egyptian Journal of Otolaryngology, 2017, 33 (3) : 573 - 578
  • [18] Efficacy of rituximab in treating steroid-resistant Graves' orbitopathy in active moderate-to-severe and sight-threatening forms: A retrospective observation from China
    Zhang, Ziyin
    Feng, Xiaohui
    Guo, Yaoyao
    Kang, Xiaonan
    Wang, Dan
    Zhang, Jing
    Zeng, Zhixuan
    Yuan, Gang
    HELIYON, 2024, 10 (11)
  • [19] Enduring remission of active and sight-threatening Graves' orbitopathy with rituximab: report of two cases
    Adamidouo, Fotini
    Anagnostiso, Panagiotis
    Boboridis, Kostas
    Manani, Christina
    Georgiou, Thomas
    Veneti, Stavroula
    Kita, Marina
    ENDOCRINE JOURNAL, 2018, 65 (09) : 963 - 967
  • [20] Management of patients with graves' orbitopathy according to EUGOGO (european group on Graves' orbitopathy) consensus statement
    Jaki-Mekjavic, Polona
    Beltram, Matej
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2010, 79 : 34 - 38